These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3781329)

  • 1. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.
    Bolton RP; Culshaw MA
    Gut; 1986 Oct; 27(10):1169-72. PubMed ID: 3781329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous metronidazole for the treatment of Clostridium difficile colitis.
    Friedenberg F; Fernandez A; Kaul V; Niami P; Levine GM
    Dis Colon Rectum; 2001 Aug; 44(8):1176-80. PubMed ID: 11535859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Clostridium difficile-induced colitis, Part 2.
    Reinke CM; Messick CR
    Am J Hosp Pharm; 1994 Aug; 51(15):1892-901; quiz 1958-9. PubMed ID: 7942924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of antibiotic-associated pseudomembranous colitis after parenteral metronidazole therapy and cure by oral vancomycin: case report.
    Meuwissen SG; Rietra PJ; Mulder CJ; Reiss M; Visser J; Van Leeuwen AM
    Neth J Med; 1981; 24(1):10-3. PubMed ID: 7207690
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.
    Musher DM; Logan N; Mehendiratta V; Melgarejo NA; Garud S; Hamill RJ
    J Antimicrob Chemother; 2007 Apr; 59(4):705-10. PubMed ID: 17337513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole: an alternate therapy for antibiotic-associated colitis.
    Cherry RD; Portnoy D; Jabbari M; Daly DS; Kinnear DG; Goresky CA
    Gastroenterology; 1982 May; 82(5 Pt 1):849-51. PubMed ID: 7060906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection.
    Kelly CP; LaMont JT
    Annu Rev Med; 1998; 49():375-90. PubMed ID: 9509270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic-induced pseudomembranous Clostridium difficile colitis. A new etiopathogenetically definable infectious disease].
    Werner H
    Fortschr Med; 1979 Sep; 97(33):1411-4. PubMed ID: 488887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis.
    Oliva SL; Guglielmo BJ; Jacobs R; Pons VG
    J Infect Dis; 1989 Jun; 159(6):1154-5. PubMed ID: 2491408
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between faecal metronidazole and lactoferrin concentrations to clinical response of patients with Clostridioides difficile.
    Saunders M; Jeffery J; Vincent Z; Ayling RM; Lewis S
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1781-1784. PubMed ID: 32281016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic trials of antibiotic associated colitis.
    Mogg GA; Arabi Y; Youngs D; Johnson M; Bentley S; Burdon DW; Keighley MR
    Scand J Infect Dis Suppl; 1980; (Suppl 22):41-5. PubMed ID: 7010533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recurrent Clostridium difficile enterocolitis].
    Bergamin B; Hess T; Jost R; Ballmer PE; Imoberdorf R
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1681-4. PubMed ID: 11103440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal use of vancomycin.
    Bublin JG; Barton TL
    Ann Pharmacother; 1994 Dec; 28(12):1357-8. PubMed ID: 7696727
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful treatment of life-threatening, treatment resistant Clostridium difficile infection associated pseudomembranous colitis with faecal transplantation].
    Nagy GG; Várvölgyi C; Paragh G
    Orv Hetil; 2012 Dec; 153(52):2077-83. PubMed ID: 23261996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parenteral therapy for antibiotic-associated pseudomembranous colitis.
    Kleinfeld DI; Sharpe RJ; Donta ST
    J Infect Dis; 1988 Feb; 157(2):389. PubMed ID: 3335816
    [No Abstract]   [Full Text] [Related]  

  • 18. The clinical spectrum of Clostridium difficile colitis in immunocompromised patients.
    Schweitzer MA; Sweiss I; Silver DL; Stellato TA
    Am Surg; 1996 Jul; 62(7):603-7; discussion 607-8. PubMed ID: 8651560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous tigecycline in patients with severe Clostridium difficile infection: a retrospective observational cohort study.
    Gergely Szabo B; Kadar B; Szidonia Lenart K; Dezsenyi B; Kunovszki P; Fried K; Kamotsay K; Nikolova R; Prinz G
    Clin Microbiol Infect; 2016 Dec; 22(12):990-995. PubMed ID: 27599690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitazoxanide for the treatment of Clostridium difficile colitis.
    Musher DM; Logan N; Hamill RJ; Dupont HL; Lentnek A; Gupta A; Rossignol JF
    Clin Infect Dis; 2006 Aug; 43(4):421-7. PubMed ID: 16838229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.